Provided by Tiger Trade Technology Pte. Ltd.

Information

5.19
+0.12002.37%
Post-market: 5.190.0042+0.08%17:06 EDT
Volume:159.81K
Turnover:828.29K
Market Cap:251.27M
PE:21.64
High:5.21
Open:5.12
Low:5.09
Close:5.07
52wk High:6.45
52wk Low:3.74
Shares:48.41M
Float Shares:35.55M
Volume Ratio:0.94
T/O Rate:0.45%
Dividend:0.18
Dividend Rate:3.47%
EPS(TTM):0.2399
EPS(LYR):0.1900
ROE:12.30%
ROA:6.36%
PB:2.62
PE(LYR):27.32

Loading ...

Image Information 1Q Loss Y34.00m vs Loss Y25.00m

Dow Jones
·
Aug 13

ISG Says Brazilian Firms Adopt Microsoft AI, Step up Governance Amid Regulatory Shifts

Reuters
·
Aug 12

Shandong New Beiyang Information Technology Wins Bid to Supply Mail Sorting Equipment

MT Newswires Live
·
Aug 12

Digital Information Technologies posts steady sales growth and maintains robust shareholder returns

TIPRANKS
·
Aug 12

Digital Information Techs FY Net Y2.09b vs Net Y2.18b

Dow Jones
·
Aug 12

Visual Guide: Shanghai's 15th Five-Year Plan for Software and IT Services

Deep News
·
Aug 12

CBA Publishes Basel III Capital and Risk Disclosures for June 2026

TIPRANKS
·
Aug 12

Agriculture Department taps C3 AI to trim Salesforce use, The Information says

TIPRANKS
·
Aug 12

ISG Report Says Swiss Firms Step up AI Governance in Future-of-Work Strategies

Reuters
·
Aug 11

Lan Fa Textile Appoints Chief Information Security Officer; Shares Down 4%

MT Newswires Live
·
Aug 11

Talkweb Information System H1 Profit Down 12%, Revenue Ticks Up 0.4%

MT Newswires Live
·
Aug 10

Keymed Biosciences (SEHK:2162) Hits A Phase III Milestone, Is The Upside Already Priced In?

Simply Wall St.
·
Aug 10

Luzhu Biotech’s Herpes Zoster Vaccine LZ901 Shows Strong Phase III Results in China

TIPRANKS
·
Aug 09

Seri Industrial Publishes Merger Information Document with Related Party SE.RI.

TIPRANKS
·
Aug 09

Smartiks Yazilim AS Updates Head Office Contact Information

TIPRANKS
·
Aug 08

Fosun Pharma Launches Head-to-Head Phase 3 Clinical Trial for a First-in-Class Drug

Deep News
·
Aug 07

Alebund’s AP301 NDA Accepted in China After Strong Phase III Dialysis Data

TIPRANKS
·
Aug 07

CR Double-Crane Pharmaceutical's Unit Completes Registration of Phase III Trial of Pregabalin Tablets

MT Newswires Live
·
Aug 07

Press Release: Tetragon Financial Group Limited Dividend Information in Respect of Q2 2026

Dow Jones
·
Aug 07

Artiva Therapeutics: Buy Rating Reiterated on Strong AlloNK RA Profile and Upcoming Phase III, Price Target Maintained at $41

TIPRANKS
·
Aug 07